The controlled decomposition of Pt2(dba)3 (dba = dibenzylideneacetone) dispersed in 1-n-butyl-3-methylimidazolium tetrafluoroborate (BMI.BF4) and hexafluorophosphate (BMI.PF6) ionic liquids in the presence of cyclohexene by molecular hydrogen produces Pt0 nanoparticles. The formation of these nanoparticles follows the two-step [A --> B, A + B --> 2B (k1, k2)] autocatalytic mechanism. The catalytic activity in the hydrogenation of cyclohexene is influenced by the nature of the anion rather than the mean-diameter of the nanoparticles. Thus, higher catalytic activity was obtained with Pt0 dispersed in BMI.BF4 containing the less coordinating anion although these nanoparticles possess a larger mean diameter (3.4 nm) than those obtained in BMI.PF6 (2.3 nm). Similar mean diameter values were estimated from in situ XRD and SAXS. XPS analyses clearly show the interactions of the ionic liquid with the metal surface demonstrating the formation of an ionic liquid protective layer surrounding the platinum nanoparticles. SAXS analysis indicated the formation of a semi-organized ionic liquid layer surrounding the metal particles with an extended molecular length of around 2.8 nm in BMI.BF4 and 3.3 nm in BMI.PF6.

A new and straightforward method for screening highly catalytically active silver nanoparticle-polymer composites derived from branched polyethyleneimine (PEI) is reported. The one-step systematic derivatization of the PEI scaffold with alkyl (butyl or octyl) and ethanolic groups led to a structural diversity correlated to the stabilization of silver nanoparticles and catalysis. Analysis of PEI derivative libraries identified a silver nanoparticle-polymer composite that was able to efficiently catalyze the p-nitrophenol reduction by NaBH(4) in water with a rate constant normalized to the surface area of the nanoparticles per unit volume (k(1)) of 0.57 s(-1) m(-2) L. Carried out in the presence of excess NaBH(4), the catalytic reaction was observed to follow pseudo-first-order kinetics and the apparent rate constant was linearly dependent on the total surface area of the silver nanoparticles (Ag-NPs), indicating that catalysis takes place on the surface of the nanoparticles. All reaction kinetics presented induction periods, which were dependent on the concentration of substrates, the total surface of the nanoparticles, and the polymer composition. All data indicated that this induction time is related to the resistance to substrate diffusion through the polymer support. Hydrophobic effects are also assumed to play an important role in the catalysis, through an increase in the local substrate concentration.

For dephosphorylation of bis(2,4-dinitrophenyl) phosphate (BDNPP) by hydroxylamine in water, pH region 4-12, the observed first-order rate constant, k(obs), initially increases as a function of pH, but is pH-independent between pH 7.2 and pH 10. The initial BDNPP cleavage by nonionic NH(2)OH (<0.2 M) involves attack by the OH group and follows first-order kinetics, but the overall initial reaction of BDNPP liberates ca. 1.7 mol of 2,4-dinitrophenoxide ion (DNP). This initial reaction generates a short-lived O-phosphorylated hydroxylamine, 2, followed by three possible reactions: (1) reaction of 2 with hydroxylamine, generating 2,4-dinitrophenyl phosphate (DNPP, 3), which subsequently forms DNP; (2) intramolecular displacement of the second DNP group and rapid decomposition of the cyclic intermediate to form phosphonohydroxylamine and eventually inorganic phosphate; (3) a novel rearrangement with intramolecular aromatic nucleophilic substitution involving a cyclic intermediate and migration of the 2,4-dinitrophenyl group from O to N. Values of k(obs) increase modestly with pH > 10, the reaction is biphasic, and the yield of DNP increases. An increase in [NH(2)OH] also increases the yield of DNP, due largely to accelerated hydrolysis of DNPP.

The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless release of active drugs on tumor sites from antibody−drug conjugates (ADCs) and caged prodrugs. We have developed a metal-mediated bond-cleavage reaction that uses platinum complexes [K 2 PtCl 4 or Cisplatin (CisPt)] for drug activation. Key to the success of the reaction is a water-promoted activation process that triggers the reactivity of the platinum complexes. Under these conditions, the decaging of pentynoyl tertiary amides and N-propargyls occurs rapidly in aqueous systems. In cells, the protected analogues of cytotoxic drugs 5fluorouracil (5-FU) and monomethyl auristatin E (MMAE) are partially activated by nontoxic amounts of platinum salts. Additionally, a noninternalizing ADC built with a pentynoyl traceless linker that features a tertiary amide protected MMAE was also decaged in the presence of platinum salts for extracellular drug release in cancer cells. Finally, CisPt-mediated prodrug activation of a propargyl derivative of 5-FU was shown in a colorectal zebrafish xenograft model that led to significant reductions in tumor size. Overall, our results reveal a new metal-based cleavable reaction that expands the application of platinum complexes beyond those in catalysis and cancer therapy.